Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
Sexually Transmitted Infections
|
February 21, 2013
Do HIV POCT testing algorithms help in clinical practice?
Richard Stack, Sundhiya Mandalia, Alan McOwan
The Journal of Infection
|
June 21, 2011
How common is the non-nucleoside reverse transcriptase inhibitor mutation E138K in clinical practice?
Daniel Bradshaw, Sundhiya Mandalia, Mark Nelson
The Journal of Infection
|
February 12, 2014
Do resistance patterns vary between different FTC containing drug regimens?
Liza Chacko, Florence Chamberlain, Sundhiya Mandalia, et al.
Journal of Wound Care
|
July 14, 2021
Pretibial injuries: to graft or to dress?
Christian Asher, Elliott Smock, Sundhiya Mandalia, et al.
AIDS (London, England)
|
January 25, 2002
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
John C Walsh, Sundhiya Mandalia, Brian G Gazzard
AIDS (London, England)
|
November 21, 2007
Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience
Laura J Waters, Sundhiya Mandalia, Brian Gazzard, et al.
The Journal of Infection
|
December 11, 2007
Hospital-based study of viridans streptococcal bacteraemia in children and adults
Lionel K K Tan, Sandra Lacey, Sundhiya Mandalia, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study
Cheryl Battersby, Nick Longford, Sundhiya Mandalia, et al.
AIDS (London, England)
|
October 9, 2002
The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients
Alan Winston, Sundhiya Mandalia, Deenan Pillay, et al.
AIDS (London, England)
|
July 1, 2011
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
Neesha Rockwood, Sundhiya Mandalia, Mark Bower, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
Sexually Transmitted Infections
|
February 21, 2013
Do HIV POCT testing algorithms help in clinical practice?
Richard Stack, Sundhiya Mandalia, Alan McOwan
The Journal of Infection
|
June 21, 2011
How common is the non-nucleoside reverse transcriptase inhibitor mutation E138K in clinical practice?
Daniel Bradshaw, Sundhiya Mandalia, Mark Nelson
The Journal of Infection
|
February 12, 2014
Do resistance patterns vary between different FTC containing drug regimens?
Liza Chacko, Florence Chamberlain, Sundhiya Mandalia, et al.
Journal of Wound Care
|
July 14, 2021
Pretibial injuries: to graft or to dress?
Christian Asher, Elliott Smock, Sundhiya Mandalia, et al.
AIDS (London, England)
|
January 25, 2002
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
John C Walsh, Sundhiya Mandalia, Brian G Gazzard
AIDS (London, England)
|
November 21, 2007
Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience
Laura J Waters, Sundhiya Mandalia, Brian Gazzard, et al.
The Journal of Infection
|
December 11, 2007
Hospital-based study of viridans streptococcal bacteraemia in children and adults
Lionel K K Tan, Sandra Lacey, Sundhiya Mandalia, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study
Cheryl Battersby, Nick Longford, Sundhiya Mandalia, et al.
AIDS (London, England)
|
October 9, 2002
The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients
Alan Winston, Sundhiya Mandalia, Deenan Pillay, et al.
AIDS (London, England)
|
July 1, 2011
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
Neesha Rockwood, Sundhiya Mandalia, Mark Bower, et al.
Page
of 10